Blood Pressure最新文献

{"title":"Dual-impedance cardiography for the assessment of arterial stiffness: associations with blood pressure, cardiometabolic risk factors, and preclinical atherosclerosis in midlife adults.","authors":"Caitlin M DuPont, Trevor M Weis, Jaya A King, Kristen T Stopfer, Colter K Clayton, Anna L Marsland, Thomas W Kamarck, Peter J Gianaros, Mark R Scudder","doi":"10.1080/08037051.2025.2600733","DOIUrl":"10.1080/08037051.2025.2600733","url":null,"abstract":"<p><strong>Purpose: </strong>Pulse wave velocity (PWV) is a measure of arterial stiffness that reflects vascular ageing and predicts risk for cardiovascular disease. We developed a PWV measurement method that uses dual-impedance cardiography (d-ICG) to address limitations of other common methods (e.g. ultrasound, tonometry, etc.), as well as to enable PWV assessments across a broader range of populations. This pre-registered, cross-sectional study tested for the first time the extent to which d-ICG PWV associates with cardiometabolic risk factors (i.e. blood pressure and other metabolic syndrome components) and vascular markers of preclinical atherosclerosis (i.e. carotid-artery intima-media thickness [C-IMT] and plaque).</p><p><strong>Methods: </strong>Participants were 366 healthy adults (aged 28-57; 63.4% female). In a subsample (<i>N</i> = 179), estimates of d-ICG PWV were compared for the first time against carotid-femoral PWV (cfPWV) measured by a Complior device.</p><p><strong>Results: </strong>d-ICG PWV and cfPWV measures were comparably associated with age and blood pressure (<i>r</i>'s ≥ .28, <i>p</i>'s ≤ .001), and they exhibited moderate consistency (ICCs = 0.51 to 0.55, <i>p</i>'s < .001). Across all cardiometabolic risk factors and markers of preclinical atherosclerosis, there were no clinically meaningful differences in the average composite (Fisher's Z-score) correlations with arterial stiffness measured by d-ICG and cfPWV based on Cohen's <i>q</i> values (<i>q</i>'s = 0.042 to 0.097).</p><p><strong>Conclusion: </strong>d-ICG PWV may be a low-cost, reliable, and alternative method for obtaining estimates of arterial stiffness that track with cardiometabolic risk factors and preclinical atherosclerosis.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2600733"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145713094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Interpreting evidence on acupuncture for hypertension: methodological and clinical perspectives.","authors":"Yun Jin Kim","doi":"10.1080/08037051.2026.2673692","DOIUrl":"10.1080/08037051.2026.2673692","url":null,"abstract":"","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2673692"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147926073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comment on 'long term efficacy and safety of first and second generation baroreflex activation devices in a refractory hypertension'.","authors":"Anushka, Mousumi Saha, Tai Yayum, Subhasish Chatterjee","doi":"10.1080/08037051.2026.2651502","DOIUrl":"https://doi.org/10.1080/08037051.2026.2651502","url":null,"abstract":"","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"35 1","pages":"2651502"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147687993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Expanding hypertension management through a behavioural counselling perspective: reflections on specialist and non-specialist practice differences.","authors":"Muchammad Syuhada', Budi Purwoko, Bakhrudin All Habsy, Mochamad Nursalim, Elisabeth Christiana","doi":"10.1080/08037051.2026.2689205","DOIUrl":"10.1080/08037051.2026.2689205","url":null,"abstract":"","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2689205"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148270122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Insights from pharmacists in the United Kingdom on the management of medication adherence in hypertension: a cross-sectional survey.","authors":"Hanad Osman, Sian Jenkins, Michel Burnier, Kamlesh Khunti, Samuel Seidu, Pankaj Gupta","doi":"10.1080/08037051.2026.2666503","DOIUrl":"10.1080/08037051.2026.2666503","url":null,"abstract":"<p><strong>Objective: </strong>To explore perceptions, behaviours and barriers of pharmacists in the United Kingdom regarding medication adherence management in hypertension.</p><p><strong>Methods: </strong>A cross-sectional online questionnaire, adapted from the European Ascertaining Barriers for Compliance (ABC) project, was distributed to UK-registered pharmacists between January and June 2024. The survey included 19 questions across six domains: participant characteristics, beliefs, adherence assessment methods, interventions, barriers and training. Descriptive analysis was performed.</p><p><strong>Results: </strong>Seventy-six pharmacists responded (53.9% male; 35.5% hospital, 31.6% primary care, 26.3% community). Nearly all (97.4%) agreed that patients' concerns affect adherence. Assessment relied mainly on asking about missed doses (60.5% frequently/always), while objective methods were rarely used, including chemical adherence testing (67.1% never), electronic monitoring (79.8%) and questionnaires (55.4%). Key barriers were high workload (56.6%), limited consultation time (52.6%) and poor interprofessional coordination (51.3%). Most respondents reported insufficient training: 77.3% wanted more undergraduate training and 60.5% had none post-registration; 86.7% did not use guideline recommendations.</p><p><strong>Conclusions: </strong>UK pharmacists recognise the importance of adherence but lack the time, tools and training to assess it systematically. Addressing system-level barriers and strengthening adherence education are essential to support their expanding role in hypertension management.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2666503"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147761395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinicians' time in different aspects of hypertension care: how far are we from optimal management required by guidelines? Results of an international survey of the working group of general practitioners' and team-based care of the European Society of Hypertension and the European General Practice Research Network.","authors":"Miriam Pikkemaat, Rosa de Pinho, Enrique Rodilla, Thomas Weber, Reinhold Kreutz, Thomas Frese, Minna Johansson, Bojan Jelakovic, Valerija Bralic Lang, Nina Dahle, Péter Torzsa, Andrew Oostindjer, Nikolaos Evangelidis, Areti Triantafyllou, Michael Doumas, Evangelos Fragkoulis, Fabio Albini, Jean-Marc Boivin, Anders Norrman, Andreas Stomby, János Nemcsik","doi":"10.1080/08037051.2026.2635826","DOIUrl":"10.1080/08037051.2026.2635826","url":null,"abstract":"<p><strong>Background: </strong>Hypertension management guidelines provide recommendations for optimal patient care. However, the limited time available of clinicians is rarely considered. The aim of this study was to evaluate the time clinicians currently spend on different components of hypertension care during an average workday and to assess physicians' perceptions of the time required for optimal, guideline-based care.</p><p><strong>Methods: </strong>We conducted an international, cross-sectional, anonymous questionnaire-based survey among physicians involved in hypertension care. A 37-item questionnaire assessed time spent on, and time perceived as necessary for, guideline-recommended hypertension-related activities during an average workday. The survey was distributed through the European Society of Hypertension (ESH) and the European General Practice Research Network (EGPRN) between 1 June and 15 September 2025.</p><p><strong>Results: </strong>370 responses were collected from 49 countries worldwide (91.3% from Europe). After data clarification 357 responses were analysed. Of these, 153 (42.9%) were general practitioners (GPs) and 204 (57.1%) were other specialists (internists, cardiologists, nephrologists). Across all assessed activities, clinicians consistently reported a gap between the time currently spent and the time perceived as necessary for optimal care, including office blood pressure measurement, home blood pressure measurement education, lifestyle counselling, and cardiovascular risk stratification. Differences were also observed between the practice of GPs and other specialists.</p><p><strong>Conclusions: </strong>This international survey demonstrates substantial perceived gaps between available and required time for several components of hypertension care, particularly in general practice. These findings highlight the importance of considering real-world clinician time constraints in the development and prioritisation of hypertension guideline recommendations and suggest that adequate health-system resources are needed to support their implementation.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2635826"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147269548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and factors associated with isolated systolic hypertension among middle-aged adults and older Filipinos: a population-based study.","authors":"Maria Stephanie N Parani, Chona F Patalen, Ma Lynell V Maniego, Eisley Jadd V Taylo, Ma Lilibeth P Dasco, Charmaine A Duante","doi":"10.1080/08037051.2026.2629094","DOIUrl":"10.1080/08037051.2026.2629094","url":null,"abstract":"<p><strong>Background: </strong>Isolated systolic hypertension (ISH), defined as blood pressure of ≥140/<90 mmHg, is associated with an increased risk of cardiovascular complications yet few estimates of prevalence are recorded globally. Data on blood pressure measurements of adult Filipinos were taken as one of the variables in the National Nutrition Survey; however, the prevalence of ISH and its associated risk factors has not been investigated. This study aimed to determine the prevalence and factors associated with ISH among middle-aged (40-59 years) and older (60 and above) Filipinos.</p><p><strong>Methods: </strong>A secondary data analysis of the cross-sectional survey design of the 2018, 2019, and 2021 Expanded National Nutrition Survey (ENNS) of the Department of Science and Technology-Food and Nutrition Research Institute (DOST-FNRI) was utilised in the study. Multivariable logistic regression analysis was employed to determine the factors significantly associated with ISH.</p><p><strong>Results: </strong>The prevalence of ISH from the pooled data was 9.10% (95% CI: 8.68-9.53) and increased significantly with age. After adjustment, multivariable analysis identified several factors significantly associated with ISH, the factors included: age, with those 70 years old of age or older exhibiting the highest odds [AOR 11.71 (95% CI: 8.38-16.35)], having little to no formal education [AOR 1.39 (95% CI: 1.18-1.64)], the presence of diabetes [AOR 1.62 (95% CI: 1.38-1.90)], or prediabetic [AOR 1.37 (95 CI: 1.13-1.66)], a family history of hypertension [AOR 2.26 (95% CI: 2.03-2.52)], and current alcohol drinker [AOR 1.24 (95% CI: 1.08-1.43)].</p><p><strong>Conclusion: </strong>ISH was prevalent among middle-aged and older Filipino population across the three survey periods. Given the impact of ISH on cardiovascular outcomes, these findings may provide crucial data on its prevalence and determinants, which can assist policymakers in formulating targeted interventions centred on lifestyle modifications.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2629094"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146155805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Elevated lipoprotein(a) levels are associated with adverse left ventricular geometric remodeling in non-diabetic patients with essential hypertension.","authors":"Tolga Kunak, Ayşegül Ülgen Kunak, İbrahim Başarıcı","doi":"10.1080/08037051.2026.2694849","DOIUrl":"10.1080/08037051.2026.2694849","url":null,"abstract":"<p><strong>Background: </strong>Lipoprotein(a) [Lp(a)] is an established cardiovascular risk factor associated with inflammation, endothelial dysfunction, oxidative stress, and arterial stiffness. Although elevated Lp(a) levels are linked to cardiovascular disease, their association with left ventricular (LV) geometric remodelling in hypertension remains incompletely understood. This study aimed to evaluate the relationship between serum Lp(a) levels and LV geometry in non-diabetic patients with essential hypertension.</p><p><strong>Methods: </strong>This cross-sectional observational study included 110 non-diabetic patients with essential hypertension. Patients were classified into low Lp(a) (<50 mg/dL, n=70) and elevated Lp(a) (≥50 mg/dL, n=40) groups. Comprehensive transthoracic echocardiography was performed to assess LV mass index (LVMI), relative wall thickness, and LV geometric patterns. Correlation and multivariate regression analyses were used to determine the independent association between Lp(a) levels and LV remodelling parameters.</p><p><strong>Results: </strong>Patients with elevated Lp(a) levels had significantly higher LVMI compared with those with lower levels (139.6±28.5 vs. 117.6±24.2 g/m², p<0.001). Concentric LV hypertrophy was more prevalent in the elevated Lp(a) group (55.0% vs. 20.0%, p=0.001). Serum Lp(a) levels were positively correlated with LVMI (r=0.357, p<0.001) and remained independently associated with LVMI after adjustment for clinical confounders (β=0.363, p<0.001). Elevated Lp(a) levels were also independently associated with increased odds of concentric LV hypertrophy.</p><p><strong>Conclusions: </strong>Elevated serum Lp(a) levels are independently associated with adverse LV geometric remodelling and concentric hypertrophy in non-diabetic patients with essential hypertension. Measurement of Lp(a) may provide additional information for cardiovascular risk stratification and early identification of hypertensive patients at risk for target organ damage.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2694849"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148306947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Methodological considerations in 'characteristics of post-exercise responders versus non-responders following aerobic or isometric exercise in physically inactive adults of African and South Asian descent with high-normal blood pressure or grade I hypertension'.","authors":"Anamika Rajpoot","doi":"10.1080/08037051.2026.2736956","DOIUrl":"https://doi.org/10.1080/08037051.2026.2736956","url":null,"abstract":"","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"35 1","pages":"2736956"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149011758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-term stability and blood pressure change tracking with a cuffless wearable device in hypertensive patients.","authors":"Martin Proença, Pierre-Antonin Rigon, Guillaume Bonnier, Damien Ferrario, Joachim Zahnd, Mathieu Lemay, Grégoire Wuerzner","doi":"10.1080/08037051.2026.2707794","DOIUrl":"10.1080/08037051.2026.2707794","url":null,"abstract":"<p><strong>Background: </strong>Reliable tracking of short- and long-term blood pressure (BP) changes is a prerequisite for clinical adoption of cuffless BP devices. This study evaluated the 6-week stability of BP estimation by CSEM's wearable photoplethysmography (PPG)-based cuffless BP monitor and its ability to track BP changes in hypertensive patients compared with a validated oscillometric device (Microlife WatchBP Home A).</p><p><strong>Methods: </strong>In this feasibility method-comparison study, 30 hypertensive patients attended four visits over 6 weeks. At each visit, BP was estimated as the median of 5-7 consecutive measurements obtained with the cuff-based (Cuff BP) and cuffless (PPG BP) devices. Between-visit systolic and diastolic BP changes (ΔSBP, ΔDBP) were compared between devices. Concordance rate (CR), defined as the percentage of significant BP changes (ΔSBP >15 mmHg, ΔDBP >10 mmHg) showing the same direction with both devices, was also assessed.</p><p><strong>Results: </strong>Thirty participants (18 women; age 54 ± 17 years; BMI 29.2 ± 5.5 kg/m²) were included. Differences between devices were 0.2 ± 12.8 mmHg for ΔSBP and -0.1 ± 7.4 mmHg for ΔDBP. No temporal drift in differences between Cuff ΔBP and PPG ΔBP was observed over 6 weeks. CR for significant BP changes was 83% for SBP and 86% for DBP.</p><p><strong>Conclusion: </strong>CSEM's wearable cuffless BP monitor provided stable BP estimation and concordant BP tracking during antihypertensive therapy. Interpretation is tempered by substantial variability of the oscillometric reference device. If confirmed in larger studies against a gold-standard reference, these findings could support the clinical acceptance of wearable cuffless BP monitoring.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2707794"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149023869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}